Literature DB >> 32197069

Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development.

Carissa Dege1, Katherine H Fegan2, J Philip Creamer1, Melissa M Berrien-Elliott3, Stephanie A Luff1, Darren Kim1, Julia A Wagner3, Paul D Kingsley2, Kathleen E McGrath2, Todd A Fehniger3, James Palis4, Christopher M Sturgeon5.   

Abstract

Natural killer (NK) cells are a critical component of the innate immune system. However, their ontogenic origin has remained unclear. Here, we report that NK cell potential first arises from Hoxaneg/low Kit+CD41+CD16/32+ hematopoietic-stem-cell (HSC)-independent erythro-myeloid progenitors (EMPs) present in the murine yolk sac. EMP-derived NK cells and primary fetal NK cells, unlike their adult counterparts, exhibit robust degranulation in response to stimulation. Parallel studies using human pluripotent stem cells (hPSCs) revealed that HOXAneg/low CD34+ progenitors give rise to NK cells that, similar to murine EMP-derived NK cells, harbor a potent cytotoxic degranulation bias. In contrast, hPSC-derived HOXA+ CD34+ progenitors, as well as human cord blood CD34+ cells, give rise to NK cells that exhibit an attenuated degranulation response but robustly produce inflammatory cytokines. Collectively, our studies identify an extra-embryonic origin of potently cytotoxic NK cells, suggesting that ontogenic origin is a relevant factor in designing hPSC-derived adoptive immunotherapies.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EMP; HSC-independent; adoptive immunotherapy; definitive hematopoiesis; erythro-myeloid progenitor; human pluripotent stem cells; natural killer cells; ontogeny; primitive hematopoiesis; yolk sac

Mesh:

Year:  2020        PMID: 32197069      PMCID: PMC7185477          DOI: 10.1016/j.devcel.2020.02.016

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  52 in total

1.  CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Suchitra Pandey; Vanessa A York; Janice Arakawa-Hoyt; Hanspeter Pircher; Philip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

2.  Three pathways to mature macrophages in the early mouse yolk sac.

Authors:  Julien Y Bertrand; Abdelali Jalil; Michèle Klaine; Steffen Jung; Ana Cumano; Isabelle Godin
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

3.  Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4.

Authors:  J Philip Creamer; Carissa Dege; Qihao Ren; Jolie T K Ho; Mark C Valentine; Todd E Druley; Christopher M Sturgeon
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

4.  C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages.

Authors:  Guillaume Hoeffel; Jinmiao Chen; Yonit Lavin; Donovan Low; Francisca F Almeida; Peter See; Anna E Beaudin; Josephine Lum; Ivy Low; E Camilla Forsberg; Michael Poidinger; Francesca Zolezzi; Anis Larbi; Lai Guan Ng; Jerry K Y Chan; Melanie Greter; Burkhard Becher; Igor M Samokhvalov; Miriam Merad; Florent Ginhoux
Journal:  Immunity       Date:  2015-04-21       Impact factor: 31.745

Review 5.  A view of human haematopoietic development from the Petri dish.

Authors:  Andrea Ditadi; Christopher M Sturgeon; Gordon Keller
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-23       Impact factor: 94.444

6.  Identification of a Human Natural Killer Cell Lineage-Restricted Progenitor in Fetal and Adult Tissues.

Authors:  Virginie M Renoux; Alya Zriwil; Claudia Peitzsch; Jakob Michaëlsson; Danielle Friberg; Shamit Soneji; Ewa Sitnicka
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

Review 7.  Early hematopoiesis and macrophage development.

Authors:  Kathleen E McGrath; Jenna M Frame; James Palis
Journal:  Semin Immunol       Date:  2016-03-25       Impact factor: 11.130

8.  Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.

Authors:  Petter S Woll; Bartosz Grzywacz; Xinghui Tian; Rebecca K Marcus; David A Knorr; Michael R Verneris; Dan S Kaufman
Journal:  Blood       Date:  2009-04-13       Impact factor: 22.113

9.  CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.

Authors:  Julia A Wagner; Maximillian Rosario; Rizwan Romee; Melissa M Berrien-Elliott; Stephanie E Schneider; Jeffrey W Leong; Ryan P Sullivan; Brea A Jewell; Michelle Becker-Hapak; Timothy Schappe; Sara Abdel-Latif; Aaron R Ireland; Devika Jaishankar; Justin A King; Ravi Vij; Dennis Clement; Jodie Goodridge; Karl-Johan Malmberg; Hing C Wong; Todd A Fehniger
Journal:  J Clin Invest       Date:  2017-10-03       Impact factor: 14.808

10.  Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells.

Authors:  Christopher M Sturgeon; Andrea Ditadi; Geneve Awong; Marion Kennedy; Gordon Keller
Journal:  Nat Biotechnol       Date:  2014-05-18       Impact factor: 54.908

View more
  24 in total

1.  Ly49E separates liver ILC1s into embryo-derived and postnatal subsets with different functions.

Authors:  Yawen Chen; Xianwei Wang; Xiaolei Hao; Bin Li; Wanyin Tao; Shu Zhu; Kun Qu; Haiming Wei; Rui Sun; Hui Peng; Zhigang Tian
Journal:  J Exp Med       Date:  2022-03-29       Impact factor: 14.307

2.  EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity.

Authors:  Ran Jing; Irene Scarfo; Mohamad Ali Najia; Edroaldo Lummertz da Rocha; Areum Han; Michael Sanborn; Trevor Bingham; Caroline Kubaczka; Deepak K Jha; Marcelo Falchetti; Thorsten M Schlaeger; Trista E North; Marcela V Maus; George Q Daley
Journal:  Cell Stem Cell       Date:  2022-08-04       Impact factor: 25.269

Review 3.  The long and winding road: homeostatic and disordered haematopoietic microenvironmental niches: a narrative review.

Authors:  Suzanne M Watt
Journal:  Biomater Transl       Date:  2022-03-28

Review 4.  All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity.

Authors:  Ariel Ramírez-Labrada; Cecilia Pesini; Llipsy Santiago; Sandra Hidalgo; Adanays Calvo-Pérez; Carmen Oñate; Alejandro Andrés-Tovar; Marcela Garzón-Tituaña; Iratxe Uranga-Murillo; Maykel A Arias; Eva M Galvez; Julián Pardo
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

Review 5.  Natural killer cell homing and trafficking in tissues and tumors: from biology to application.

Authors:  Guang He Ran; Yu Qing Lin; Lei Tian; Tao Zhang; Dong Mei Yan; Jian Hua Yu; You Cai Deng
Journal:  Signal Transduct Target Ther       Date:  2022-06-29

6.  Derivation of extra-embryonic and intra-embryonic macrophage lineages from human pluripotent stem cells.

Authors:  Andrea L Bredemeyer; Junedh M Amrute; Andrew L Koenig; Rachel A Idol; Li He; Stephanie A Luff; Carissa Dege; Jamison M Leid; Joel D Schilling; J Travis Hinson; Mary C Dinauer; Christopher M Sturgeon; Kory J Lavine
Journal:  Development       Date:  2022-05-03       Impact factor: 6.862

7.  Identification of a retinoic acid-dependent haemogenic endothelial progenitor from human pluripotent stem cells.

Authors:  Stephanie A Luff; J Philip Creamer; Sara Valsoni; Carissa Dege; Rebecca Scarfò; Analisa Dacunto; Sara Cascione; Lauren N Randolph; Eleonora Cavalca; Ivan Merelli; Samantha A Morris; Andrea Ditadi; Christopher M Sturgeon
Journal:  Nat Cell Biol       Date:  2022-04-28       Impact factor: 28.213

Review 8.  The Fetal-to-Adult Hematopoietic Stem Cell Transition and its Role in Childhood Hematopoietic Malignancies.

Authors:  Ryan Mack; Lei Zhang; Peter Breslin Sj; Jiwang Zhang
Journal:  Stem Cell Rev Rep       Date:  2021-08-23       Impact factor: 6.692

Review 9.  Location, Location, Location: How Vascular Specialization Influences Hematopoietic Fates During Development.

Authors:  Adam M Heck; Takashi Ishida; Brandon Hadland
Journal:  Front Cell Dev Biol       Date:  2020-11-13

Review 10.  Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies.

Authors:  Keerthana Shankar; Christian M Capitini; Krishanu Saha
Journal:  Stem Cell Res Ther       Date:  2020-06-16       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.